{{Rsnum
|rsid=3025035
|Gene=VEGFA
|Chromosome=6
|position=43783622
|Orientation=plus
|GMAF=0.1713
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=VEGFA
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 83.2 | 15.9 | 0.9
| HCB | 67.2 | 29.9 | 2.9
| JPT | 56.6 | 34.5 | 8.8
| YRI | 39.5 | 45.6 | 15.0
| ASW | 35.1 | 57.9 | 7.0
| CHB | 67.2 | 29.9 | 2.9
| CHD | 71.6 | 26.6 | 1.8
| GIH | 92.1 | 7.9 | 0.0
| LWK | 54.5 | 38.2 | 7.3
| MEX | 87.9 | 12.1 | 0.0
| MKK | 57.1 | 35.9 | 7.1
| TSI | 85.3 | 13.7 | 1.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20082870
|Title=A Single Nucleotide Polymorphism in the Vascular Endothelial Growth Factor Gene Is Associated with Recurrence of Hepatocellular Carcinoma after Transplantation
}}

{{PMID|17319747|OA=1
}} Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk.

{{PMID|19308252|OA=1
}} Genetic variation in VEGF does not contribute significantly to the risk of congenital cardiovascular malformation.

{{PMID|20019880|OA=1
}} Polymorphisms in the VEGFA and VEGFR-2 genes and neovascular age-related macular degeneration.

{{PMID|22116284}} A two-step genetic study on quantitative precursors of coronary artery disease in a homogeneous Indian population: case-control association discovery and validation by transmission-disequilibrium test.

{{PMID Auto
|PMID=24039754
|Title=The impact of polymorphic variations in the 5p15, 6p12, 6p21 and 15q25 Loci on the risk and prognosis of portuguese patients with non-small cell lung cancer
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}